Physician profile
Peter Pyrko
NPI 1467695056
$2,042.90
in general payments reported to CMS, 2019-2025
11 companies · $199 in 2025
The $199 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $844 · 2020: $651 · 2021: $231 · 2023: $24.13 · 2024: $94.38 · 2025: $199.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $317.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $317.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,300.59 | 2019-2025 | Mako |
| Ortho Development Corporation | $231.70 | 2019-2020 | |
| Integra Lifesciences Corporation | $118.49 | 2021 | |
| Cpm Medical Consultants, LLC | $95.28 | 2021 | |
| Tei Biosciences INC | $86.60 | 2019 | |
| Convatec INC. | $60.46 | 2025 | |
| Medtronic, INC. | $45.92 | 2025 | Intellis Adaptivestim |
| Saxum Surgical, INC. | $43.60 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $28.25 | 2025 | Tagrisso |
| Uoc USA INC | $17.10 | 2021 | |
| Smith+Nephew, INC. | $14.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Pyrko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.